Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # Hoffmann-La Roche
  • # DNA
  • # Diabetes
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

A New Study Reveals the Secret to a Sustained Immune Response in Cancer and Chronic Illnesses

3 February 2025

E. faecalis biofilms are targeted by a phage-derived enzyme to reduce acute Graft-Versus-Host Disease

12 July 2024

Blood test for Tuberculosis; researchers at the final phase of development

23 March 2024

An International Study Reveals That a Breakthrough in Childhood Brain Cancer Research Could Revolutionize Treatment

5 February 2025

Classifying the natural history of asymptomatic malaria – Research

7 January 2024

Abbott’s FreeStyle Libre® Technology Linked to Significant Reduction in Heart-Related Hospitalizations for Diabetes Patients

16 May 2025

Research: A new neural biomarker for OCD

14 July 2024

A single mutation to the H5N1 influenza surface protein could make human infection easier

8 December 2024

Chi-square Test – Formula and Applications

4 February 2024

Phase III Clinical Trials Shows Promising Results for Gene Therapy Against Hemophilia B

27 September 2024

New Skeletal Tissue Advances Regenerative Medicine Potential

10 January 2025

UK approves first in the world CRISPR treatment for diseases – Casgevy

17 November 2023

Editor's Desk

Understanding Prophase: Roles in Mitosis and Meiosis (Prophase I & II)
Science

Understanding Prophase: Roles in Mitosis and Meiosis (Prophase I & II)

Editor's Desk 2 June 2025

The first stage of mitosis and meiosis, two crucial cellular division processes that support an organism’s growth, repair, and reproduction, is known as prophase.The specifics of what transpires and why differ depending on the cell’s activity in either mitosis or meiosis, even though chromosomal condensation and spindle construction are shared […]

NKure Therapeutics and CRISPR Therapeutics Partner to Advance CTX112â„¢ for Cancer Treatment in India
Biotechnology Business News

NKure Therapeutics and CRISPR Therapeutics Partner to Advance CTX112â„¢ for Cancer Treatment in India

Editor's Desk 7 May 2025

Compared to existing CAR T treatments, the off-the-shelf experimental therapeutic CTX112TM may allow for quicker patient access.

Eyestem’s Eyecyte-RPE™ Trial Shows Vision Rescue for Geographic Atrophy Patients
Clinical Trials Healthcare & Pharmaceuticals News

Eyestem’s Eyecyte-RPE™ Trial Shows Vision Rescue for Geographic Atrophy Patients

Editor's Desk 15 April 2025

All nine subjects of phase 1 injected without any serious adverse events.

Abbott’s Voltâ„¢ Pulsed Field Ablation System Receives CE Mark to Treat Patients with Abnormal Heart Rhythms
Business Healthcare & Pharmaceuticals News

Abbott’s Voltâ„¢ Pulsed Field Ablation System Receives CE Mark to Treat Patients with Abnormal Heart Rhythms

Editor's Desk 31 March 2025

AFib affects around 8 million Europeans over the age of 65, and this figure is anticipated to grow over the next 30 years.

GSK Released EMBRACE a Phase 2b Clinical Trial Data of an Investigational Broadly Neutralising Antibody for HIV
Business Clinical Trials Healthcare & Pharmaceuticals News

GSK Released EMBRACE a Phase 2b Clinical Trial Data of an Investigational Broadly Neutralising Antibody for HIV

Editor's Desk 18 March 2025

The findings support the increasing amount of data showing that N6LS is a strong antiviral that may be used as part of an all-encompassing antiretroviral treatment plan.

AstraZeneca Released Satisfactory Results of 24 Weeks CALYPSO Phase III Trial for Eneboparatide
Clinical Trials Healthcare & Pharmaceuticals News

AstraZeneca Released Satisfactory Results of 24 Weeks CALYPSO Phase III Trial for Eneboparatide

Editor's Desk 17 March 2025

Trial continues as planned to 52 weeks to further characterize the risk-benefit profile.

Amgen Released Phase 3 MINT Trial Data Evaluating the Efficacy and Safety of UPLIZNA® (inebilizumab-cdon)
Clinical Trials Healthcare & Pharmaceuticals News

Amgen Released Phase 3 MINT Trial Data Evaluating the Efficacy and Safety of UPLIZNA® (inebilizumab-cdon)

Editor's Desk 14 March 2025

The trial achieved its primary endpoint, as previously revealed at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting.

Merck Announces Positive Results of Phase 3 Trials for Their HIV-1 Investigational Two-Drug Regimen Doravirine/Islatravir
Clinical Trials Healthcare & Pharmaceuticals News

Merck Announces Positive Results of Phase 3 Trials for Their HIV-1 Investigational Two-Drug Regimen Doravirine/Islatravir

Editor's Desk 13 March 2025

Islatravir, Merck’s investigational nucleoside reverse transcriptase translocation inhibitor (NRTTI), inhibits HIV-1 replication through a variety of mechanisms

Researchers Developed a More Affordable, Lower-risk Polio Vaccine
Healthcare & Pharmaceuticals Research

Researchers Developed a More Affordable, Lower-risk Polio Vaccine

Editor's Desk 12 March 2025

The current inactivated polio vaccine (IPV), which uses a destroyed form of the poliovirus to trigger an immune system response

Pfizer With Arvinas Announced Positive Results of Phase 3 VERITAC-2 Clinical Trial for Advanced or Metastatic Breast Cancer
Cancer Clinical Trials Healthcare & Pharmaceuticals News

Pfizer With Arvinas Announced Positive Results of Phase 3 VERITAC-2 Clinical Trial for Advanced or Metastatic Breast Cancer

Editor's Desk 11 March 2025

At the time of the analysis, less than 25% of the necessary number of events had taken place, indicating that overall survival was not mature.

Posts pagination

1 2 3 4 5 … 20 Next

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
  • Novo Nordisk Engineering (NNE) is Hiring a Manufacturing Execution System (MES) Analyst in Bengaluru, India
  • Sartorius is Hiring a Process Technology Engineer in Bengaluru, India – May, 2025
  • Cytiva Hiring a Logistics Specialist in Singapore – May 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy